Search Videos and More
Course
Thoracic Malignancies: A Review of the Latest Evidence
Date: Saturday, November 1, 2025 | Time: 7:30 AM - 3:30 PM
Course
2025 Practice-Changing Updates in Bladder, Kidney & Prostate Cancer
Date: Thursday, October 23, 2025 | Time: 5:45 PM - 9:00 PM
Course
24th Annual Highlights of the 2025 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this educational program is designed to support medical, radiation, and surgical oncologists, as well as gynecologists and radiologists, in translating key data from the 2025 San Antonio Breast Cancer Symposium into clinical practice.
News
A RACE AGAINST TIME AND DISEASE
“We’ve made great strides treating melanoma at Fox Chase and have built one of the most comprehensive multidisciplinary teams in the region—an expertise recognized nationally and internationally,” says Jeffrey M. Farma, MD, FACS, Chair and Professor, Department of Surgery, Fox Chase Cancer Center. “I’m thrilled to bring TIL (tumor-infiltrating lymphocyte) therapy to our metastatic melanoma patients who are not responding to their first-line treatment—a cellular therapy which requires critical timing and a highly specialized multidisciplinary team to deliver it.”
News
Aiming to Refine NSCLC Targeted Therapy
The first study to prospectively examine the impact of co-mutation biomarkers on sotorasib, a novel targeted therapy, for advanced KRAS G12C mutated NSCLC
News
Fox Chase Cancer Center Researcher Secures Funding to Investigate Toxicity Reduction in Bladder Cancer Treatment
News
A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases
Physicians at Fox Chase Cancer Center have begun accepting patients for a new clinical trial looking at the effectiveness of a hepatic artery infusion (HAI) pump along with standard chemotherapy. Fox Chase is the only local hospital offering this trial, which is designed for patients with colorectal cancer that has spread to the liver and cannot be treated with surgery.
News
Forward Celebrates Fox Chase's 50 Years
Join us on a journey that commemorates the golden anniversary of Fox Chase Cancer Center. Learn about our milestones and achievements that have changed the world of cancer care. Meet the extraordinary clinicians and researchers who made it happen.
News
ASTRO 2025 Speaker and Poster Sessions
We welcome you to stop by Booth #2310 to connect with our team and learn more about our latest offerings and initiatives
Course
AI-Powered LDCT: Temple Establishes New Paradigm for Lung Disease Detection
Pulmonologists are at the forefront of detecting and managing lung disease - and now, artificial intelligence (AI) is redefining what’s possible in early detection and workflow efficiency. The Temple Lung Center has become the first pulmonary program in the nation to integrate AI into routine lung screening, using AI software as a core diagnostic tool that supports early detection, multidisciplinary review, and streamlined patient care pathways.
News
“Being Present” for My Patients and Staff Is Fundamental to Excellent Care
Clinical Nurse Manager Tatiana Villamarin, BSN, RN, commands important roles within the world of the Fox Chase – Temple Urologic Institute: In one role, Villamarin serves as a high-level administrator-manager for two urology outpatient clinics, overseeing care and coordination for 80 to 100 patients every weekday.
News
Soaring to New Heights: Fox Chase Leadership, Faculty, Residents, and Fellows
A hallmark of Fox Chase leadership, fellows, residents and faculty is their ability to persevere—to keep climbing the often-difficult ascent of cancer discovery and delivery—no matter what. Meet some of the exceptional researchers, scientists, and clinicians determined to make decisive inroads in cancer care.